ALFA FinderBSE filing, NSE: CONCORDBIO. Summary written from the filing by ALFA Finder's alert engine.
Concord Biotech Ltd: key numbers
- Share price
- ₹599.30
- Market cap
- ₹12,539 Cr
- Revenue (annual)
- ₹1,055 Cr
- Net profit (annual)
- ₹260.9 Cr
- P/E (TTM)
- 44.4×Sector 43.8×
- Promoter holding
- 44.09%+0.01% QoQ
- FII holding
- 7.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Concord Biotech Ltd
All →Concord Biotech Bonus Issue
Concord Biotech allotted 10,46,16,204 bonus shares in a 1:1 ratio. Total equity shares rise to 20,92,32,408 after the bonus allotment.
Concord Biotech Earnings Call Transcript: Key Takeaways
Revenue grew 25% YoY driven by API demand, but gross margins contracted 400bps due to rising solvent costs and geopolitical disruptions.
- Call
- Guides 18% growth
Concord Biotech Investor Presentation: Key Takeaways
Q2FY27 consolidated revenue ₹309.1 Cr (+25%) and PAT ₹69.6 Cr (+10%); H1 revenue ₹566.6 Cr (+26%). Margins compressed; Inspira dermatology division launched.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Concord Biotech Q2 FY27 Results: Net Profit ₹69.6 Cr, Up 10.3% YoY
Concord Biotech Ltd reported revenue from operations of ₹309.1 Cr (+25.1% YoY) and net profit of ₹69.6 Cr (+10.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹69.6 Cr · +10.3% YoY
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Other other announcement announcements
All →Triveni Glass Other Announcement
Triveni Glass director Anil Kumar Dhawan bought 15,188 shares on BSE for Rs.1,43,992. Routine PIT Reg 7(2) disclosure by a non-promoter director.
- Value
- ₹0.01 Cr
GRE Renew Enertech Other Announcement
GRE Renew Enertech filed its Reg 32 quarterly statement on IPO proceeds utilisation. It reports a reallocation of funds from solar plant capex to general corporate purposes.
Vectras Enprocon Other Announcement
Director Ravi P Patel bought 12,000 Vectras Enprocon shares for Rs. 0.13 Crore on BSE. No promoter involvement in this routine market purchase.
- Value
- ₹0.13 Cr
LGT Global Hospitality Other Announcement
LGT Global Hospitality filed its quarterly Monitoring Agency Report for Q1 FY27 under ICDR 162A. The report confirms Nil deviation in utilisation of its ₹21.92 crore IPO proceeds.
Astra Microwave Products Other Announcement
Astra Microwave filed a Reg 32 statement for the quarter ended September 30, 2026. It confirms no deviation or variation in the use of preferential-issue warrant proceeds.
Rane Holdings Other Announcement
Rane Holdings filed its Q1 FY27 Reg 32 statement on use of preferential-warrant proceeds. It reported ₹10 Cr raised and ₹7.81 Cr utilised for borrowings, with no deviation.